Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05763043 · ClinicalTrials.gov registry record · Early Phase 1
Monoferric for Prenatal Iron Deficiency
A Early Phase 1 study of Obstetric Labor Complications, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05763043: Recruiting Early Phase 1 study of Obstetric Labor Complications, sponsored by Oregon Health and Science University.
NCT05763043 is a Early Phase 1 study of Obstetric Labor Complications that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 80 participants, below the 91-participant average among 3 other Obstetric Labor Complications trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05763043, a Early Phase 1 study of Obstetric Labor Complications, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.
Primary Outcome
The proportion of participants who experienced a resolution of iron deficiency anemia, defined as a 1 g/dL increase in Hgb at a follow up assessment at 6 weeks postpartum following IV Monoferric administration
Conditions Studied
Interventions
- DRUG Ferric derisomaltose
Study Locations (1)
Oregon
- Oregon Health & Science Univerity - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2028-10 |
| Phase | Early Phase 1 |
What NCT05763043 shows while recruiting
NCT05763043 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 91-participant average among 3 other Obstetric Labor Complications trials with a reported enrollment target (12% lower).
The record links to 1 condition, with Obstetric Labor Complications appearing as the primary indexed condition, and to 1 intervention - of which Ferric derisomaltose is the first listed.
NCT05763043 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05763043 about?
NCT05763043 is a clinical study titled "Monoferric for Prenatal Iron Deficiency". A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.
What is the current status of trial NCT05763043?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2024-01-18. Estimated completion is 2028-10.
What conditions does trial NCT05763043 study?
This clinical trial studies the following conditions: Obstetric Labor Complications.
What interventions are being tested in trial NCT05763043?
The interventions under investigation include: Ferric derisomaltose (DRUG).
Who is sponsoring clinical trial NCT05763043?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05763043 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstetric Labor Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI